Wednesday, October 29, 2025

Advancing Coronary Revascularization: Huanting Liu’s Hybrid RFR-FFR Strategy Revolutionizes Decision-Making in NSTE-ACS

Presenter: Huanting Liu, Guangdong Medical University, China

Presentation Type: Poster Presentation (Virtual)

Title: Hybrid RFR-FFR decision-making strategy for physiology-guided coronary revascularization in patients with non-ST elevation acute coronary syndrome
Conference:
International Conference on Cardiology and Cardiovascular Science
πŸ“… March 26–28, 2026 | πŸ“ Singapore & Online
πŸ”— Official Website


🌟 Research Overview

In an era where precision in cardiac care is paramount, Huanting Liu presents a groundbreaking hybrid RFR-FFR decision-making approach designed for physiology-guided coronary revascularization in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
This innovative study bridges the gap between diagnostic efficiency and patient safety by optimizing invasive coronary assessment methods.


🩺 Key Study Insights

·         Comprehensive Clinical Evaluation: Conducted on 253 patients (320 diseased vessels) at Cangzhou Central Hospital of Hebei Medical University between 2021–2023.

·         Hybrid Approach: Developed an RFR-FFR method to identify “gray zones” where adenosine use is selectively needed.

·         Efficiency Boost: Achieved 56.56% reduction in adenosine use without compromising diagnostic accuracy.

·         High Concordance Rate: Maintained 95.31% agreement with the FFR-only model, ensuring reliability.

·         Strong Predictive Values: Recorded 96.28% positive and 93.33% negative predictive values.

·         Clinical Advantage: Offers a safer, faster, and more cost-effective solution for coronary lesion evaluation.


πŸ‘©πŸ”¬ About the Researcher

Huanting Liu is a master’s student from Guangdong Medical University specializing in epidemiology and health statistics. Her research emphasizes data analytics and epidemiological methodologies, focusing on cardiovascular chronic diseases and evidence-based health solutions.



🌍 Join the Global Discussion

Be part of the International Conference on Cardiology and Cardiovascular Science (CVS 2026) — a premier gathering for global cardiology experts, researchers, and innovators.

πŸ“§ Email: cardiology@mathewsconference.com
πŸ“ž Phone: +1 (312) 462-4448 | WhatsApp: +1 (424) 377 0967
🧾 Submit Abstract | Register Here


#Cardiology2026 #HeartResearch #CardiovascularScience #NSTEACS #FFR #RFR #HybridApproach #CoronaryRevascularization #CardiacInnovation #CardiologyConference #MedicalResearch #SingaporeEvents

No comments:

Post a Comment

Leveraging Big Data and Artificial Intelligence for Precision Cardiovascular Care at CVS 2027

The rapid advancement of Big Data, Artificial Intelligence (AI), and Machine Learning (ML) is opening new possibilities in cardiovascular m...